Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Now available: CD-ROM of highlights from the XXII Congress of the ESC

Jan. 4, 2001

Gestilab patents compositions protecting against myocardial oxidative stress

Jan. 3, 2001

ETA receptor antagonists in various stages of clinical testing at Icos-Texas Biotechnology

Jan. 2, 2001

HIF-1 gene therapy product in clinical trial at U. of Pittsburgh Medical Center

Jan. 2, 2001

Reformulated sampatrilat shows improved bioavailability in animal model

Dec. 29, 2000

Tanabe Seiyaku claims isoquinoline derivatives with cardiovascular activity

Dec. 27, 2000

Sumitomo discloses thiourea derivatives with ECE-inhibitory activity

Dec. 27, 2000

Myogen and BASF to codevelop BSF-208075

Dec. 27, 2000

Dual inhibitors of ACE/NEP in development at Toa Eiyo

Dec. 22, 2000

Ranolazine enters phase II for CHF

Dec. 22, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...